Submit your research today!
Your valuable research in Expert Review of Clinical Immunology
About the special issue
Of the number of drugs to treat inflammatory disorders such as rheumatoid arthritis, Janus kinase (JAK) inhibitors represent one targeted therapy option that interferes with the JAK-STAT signalling pathway. By inhibiting & mediating inflammatory immune responses, they help control inflammatory diseases in patients.
Expert Review of Clinical Immunology is excited to announce a special issue on ‘The JAKi in inflammatory disorders & arthritis: lights and shadows’ with Dr James Galloway and Dr Fabiola Atzeni as guest editors. The special issue will aim to address the advances that have been made in treating inflammatory disease with JAK inhibitors, and potential challenges that stand in the way of future progress.
The issue welcomes authors to submit relevant editorials and review articles, and also relevant original research into treating inflammatory disorders with JAK inhibitors. The benefit of publishing as part of a special issue is that the articles included often receive more views and higher citation numbers.
By publishing in Expert Review of Clinical Immunology you will:
- Gain recognition from an international audience and increase your opportunities for future collaboration
- Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site
- Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
- Increase the discoverability of your research with MEDLINE listings and more